This inventor holds 34 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Antimicrobial Compounds. Top assignees: Merck + Co., Inc., Methylgene, Inc., Other. Active years: 1985-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edison, NJ (US) (1985 - 1986)
- Sommerville, NJ (US) (1988 - 1995)
- Somerville, NJ (US) (1986 - 2013)
Company Filing History:
29 out of 4,770 
1 out of 53 
4 out of 834,708 Years Active: 1985-2013
Areas of Expertise:
Title: **Milton L Hammond: A Pioneer in Pharmaceutical Innovations**
Introduction
Milton L Hammond is a distinguished inventor based in Somerville, NJ, with an impressive portfolio of 34 patents. His work spans vital areas in pharmaceutical innovations, specifically focusing on compounds that address significant health challenges.
Latest Patents
Among his latest inventions are two notable patents:
1. **Inhibitors of Beta-Lactamase** - This invention introduces novel inhibitors of the aryl- and heteroaryl-sulfonamidomethylphosphonate monoester class. These compounds contain nitrogen-based cations or quaternary ammonium groups and are designed to inhibit three classes of beta-lactamases. More importantly, they enhance the antibacterial effects of beta-lactam antibiotics, such as imipenem and ceftazidime, against microorganisms that typically showcase resistance due to beta-lactamase presence.
2. **Estrogen Receptor Modulators** - This invention pertains to compounds and their derivatives, acting as ligands for estrogen receptors. The potential applications include treatment or prevention of various conditions related to estrogen functionality, encompassing bone loss, osteoporosis, endometriosis, cardiovascular diseases, and breast, uterine, and prostate cancer.
Career Highlights
Milton has had a robust career, contributing significantly to drug development and innovative therapies. He has collaborated with prominent organizations like Merck & Company, Inc., further establishing his reputation in the pharmaceutical industry.
Collaborations
Throughout his career, Milton has worked alongside notable professionals such as Robert A Zambias and James M Balkovec. Their joint efforts have likely propelled research and innovation in the various fields they explored together, leading to fruitful advancements in pharmaceutical applications.
Conclusion
Milton L Hammond's extensive work and patents demonstrate his commitment to addressing critical health challenges through innovation. His contributions are not only influential in the pharmaceutical sector but also testify to the ongoing need for advancements in medical science to enhance patient outcomes globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile